GlassScriptPhysician profile
Joshua Peter Vrabec
NPI 1215985841
$14,820.64
in general payments reported to CMS, 2019-2025
12 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.26 · 2020: $39.91 · 2021: $192 · 2022: $3,292 · 2023: $8,247 · 2024: $2,798 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,325 · Travel and Lodging: $1,984 · Food and Beverage: $1,809 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,100 · Gift: $36.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,325.00 |
| Travel and Lodging | $1,984.22 |
| Food and Beverage | $1,808.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,100.00 |
| Gift | $36.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $8,250.00 | 2022-2024 | Iolmaster 700, Cirrus Hd-Oct, Humphrey Hfa |
| Carl Zeiss Meditec USA, INC. | $5,359.29 | 2022-2025 | Cirrus Hd-Oct, Veracity Surgical, Visumax |
| Alcon Vision LLC | $701.76 | 2019-2025 | Clareon, Clareon Panoptix Pro, Lensx |
| Johnson & Johnson Surgical Vision, INC. | $140.45 | 2019-2025 | Tecnis Iol, Catalys System |
| Rxsight INC | $123.55 | 2022-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Lensar, INC. | $114.75 | 2021 | |
| Rayner Intraocular Lenses Limited | $37.30 | 2023 | Omidria, Rayone Emv, Rayone Aspheric |
| Glaukos Corporation | $27.76 | 2023 | |
| Bausch & Lomb Americas INC. | $21.83 | 2025 | Envista Envy Iol |
| Allergan, INC. | $19.04 | 2022 | |
| Ocular Therapeutix, INC. | $13.60 | 2021 | |
| New World Medical,INC. | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Vrabec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.